NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates ("Broadwood†or "we†) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA) with the U.S. Securities and Exchange Commission ("SEC†) of a "supplement†to the Company's definitive proxy statement, filed on September 16, 2025, in connection with the proposed acquisition of STAAR by Alcon Inc. ("Alcon†) (NYSE: ALC). Broadwood, which owns 27.5% of STAAR. ...